BIOTRICITY INC.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$4M
↑+10.2% +$369Kvs FY2024 (Q4)
Gross Profit
$3M
↑+17.6% +$488Kvs FY2024 (Q4)
Operating Income
$441K
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $4M | $4M |
| COGS | $736K | $855K |
| Gross Profit | $3M | $3M |
| R&D | $624K | $551K |
| SG&A | $2M | $2M |
| D&A | $0 | $1K |
| Other OpEx | $0 | $0 |
| Operating Income | $441K | $0 |
| Interest Exp. | $441K | $0 |
| Other Non-Op | $0 | $0 |
| Pretax Income | $0 | $0 |
| Tax | $0 | $0 |
| Net Income | $0 | $0 |
QuarterCharts · SEC EDGAR data · BTCY · Comparing FY2025 (Q4) vs FY2024 (Q4)